214 related articles for article (PubMed ID: 25883990)
1. A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.
Kobayashi K; Sasaki T; Takenaka F; Yakushiji H; Fujii Y; Kishi Y; Kita S; Shen L; Kumon H; Matsuura E
J Immunol Res; 2015; 2015():268172. PubMed ID: 25883990
[TBL] [Abstract][Full Text] [Related]
2. Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
ter Weele EJ; Terwisscha van Scheltinga AG; Kosterink JG; Pot L; Vedelaar SR; Lamberts LE; Williams SP; Lub-de Hooge MN; de Vries EG
Oncotarget; 2015 Dec; 6(39):42081-90. PubMed ID: 26536664
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.
Lamberts LE; Menke-van der Houven van Oordt CW; ter Weele EJ; Bensch F; Smeenk MM; Voortman J; Hoekstra OS; Williams SP; Fine BM; Maslyar D; de Jong JR; Gietema JA; Schröder CP; Bongaerts AH; Lub-de Hooge MN; Verheul HM; Sanabria Bohorquez SM; Glaudemans AW; de Vries EG
Clin Cancer Res; 2016 Apr; 22(7):1642-52. PubMed ID: 26589435
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeting of CEACAM6 using antibody probes of different sizes.
Niu G; Murad YM; Gao H; Hu S; Guo N; Jacobson O; Nguyen TD; Zhang J; Chen X
J Control Release; 2012 Jul; 161(1):18-24. PubMed ID: 22568933
[TBL] [Abstract][Full Text] [Related]
5. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
[TBL] [Abstract][Full Text] [Related]
6. Novel single-chain variant of antibody against mesothelin established by phage library.
Yakushiji H; Kobayashi K; Takenaka F; Kishi Y; Shinohara M; Akehi M; Sasaki T; Ohno E; Matsuura E
Cancer Sci; 2019 Sep; 110(9):2722-2733. PubMed ID: 31461572
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging of Dll4 Expression in Glioblastoma and Colorectal Cancer Xenografts Using (64)Cu-Labeled Monoclonal Antibody 61B.
Zhou B; Wang H; Liu R; Wang M; Deng H; Giglio BC; Gill PS; Shan H; Li Z
Mol Pharm; 2015 Oct; 12(10):3527-34. PubMed ID: 26288060
[TBL] [Abstract][Full Text] [Related]
8.
Broer LN; Knapen DG; Suurs FV; Moen I; Giesen D; Waaijer SJH; Indrevoll B; Ellingsen C; Kristian A; Cuthbertson AS; de Groot DA; Cole PE; de Vries EGE; Hagemann UB; Lub-de Hooge MN
J Nucl Med; 2022 Nov; 63(11):1715-1721. PubMed ID: 35422447
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
[TBL] [Abstract][Full Text] [Related]
10. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
[TBL] [Abstract][Full Text] [Related]
11. In vivo imaging of therapy response to a novel pan-HER antibody mixture using FDG and FLT positron emission tomography.
Nielsen CH; Jensen MM; Kristensen LK; Dahlman A; Fröhlich C; Jacobsen HJ; Poulsen TT; Lantto J; Horak ID; Kragh M; Kjaer A
Oncotarget; 2015 Nov; 6(35):37486-99. PubMed ID: 26460961
[TBL] [Abstract][Full Text] [Related]
12. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
Wang H; Li D; Liu S; Liu R; Yuan H; Krasnoperov V; Shan H; Conti PS; Gill PS; Li Z
J Nucl Med; 2015 Jun; 56(6):908-13. PubMed ID: 25908833
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
Nucl Med Commun; 2015 Mar; 36(3):286-94. PubMed ID: 25460304
[TBL] [Abstract][Full Text] [Related]
14. Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model.
Yoshida C; Sogawa C; Tsuji AB; Sudo H; Sugyo A; Uehara T; Hino O; Yoshii Y; Fujibayashi Y; Fukumura T; Koizumi M; Arano Y; Saga T
Nucl Med Commun; 2010 May; 31(5):380-8. PubMed ID: 20072072
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors.
Misri R; Saatchi K; Ng SS; Kumar U; Häfeli UO
Nucl Med Biol; 2011 Aug; 38(6):885-96. PubMed ID: 21843785
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
17. Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
Lee JH; Kim H; Yao Z; Lee SJ; Szajek LP; Grasso L; Pastan I; Paik CH
Nucl Med Biol; 2015 Nov; 42(11):880-6. PubMed ID: 26307499
[TBL] [Abstract][Full Text] [Related]
18. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
20. 111Indium-labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin.
Hassan R; Wu C; Brechbiel MW; Margulies I; Kreitman RJ; Pastan I
Int J Cancer; 1999 Feb; 80(4):559-63. PubMed ID: 9935157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]